Page 2 - Gsk

Unilever to sell slow-growth brands as it weighs higher bid for GSK unit

The Dove soap owner said Monday it will announce a revamp of its structure later this month

Unilever eyes GSK's consumer goods arm in possible $68-bn deal

Unilever confirms interest in GSK assets, says GSK consumer business would be 'strong strategic fit'; UK's Sunday Times says 50 billion-pound bid rejected in late 2021

How the world's first malaria vaccine will protect against the parasite

This vaccine has been in development for 30 long years

GSK, CureVac's next-gen Covid vaccine shows promise in monkey trial

The encouraging news on its "second-generation" vaccine gave CureVac's German-listed shares an 8% lift, as the stock gradually recovers from a slump in June

Sanofi-GSK Covid-19 vaccine gets nod to start phase-3 trials in India

India part of 35,000 volunteer global efficacy trial

GSK's drugs arm to get $11 billion windfall from consumer spin-off

Investors have been waiting for details of the separation

Activist investor Elliott takes multibillion pound stake in GSK: Report

Shares in GSK erased losses and traded more than 7% higher

GSK fires former US govt vaccine head Slaoui over harassment allegation

GlaxoSmithKline has dismissed Moncef Slaoui as chairman of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed an employee several years ago

GSK fires former US govt vaccine head Slaoui over harassment allegation

Former U.S. President Donald Trump appointed Slaoui to lead his administration's effort to produce and distribute COVID-19 vaccines last year

GSK, CureVac to develop Covid-19 vaccines aimed at new variants

Drugmaker GlaxoSmithKline said Wednesday it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of COVID-19

British firm GSK to move malaria vaccine production to Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the malaria vaccine

GSK transfers malaria vaccine production to India's Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the vaccine

India Inc gets back to office cautiously, even as many MNCs remain shut

Many are testing hybrid models to ensure safety and hygiene; seat-booking module introduced in some companies

COVAX gains access to 2 billion doses of vaccines for 190 member economies

First deliveries are expected to begin in the first quarter of 2021 depending upon regulatory approvals and readiness of countries for delivery

Sanofi-GSK delay Covid-19 vaccine to late 2021 in setback to global fight

The two companies said they planned to start another study next February, hoping to come up with a more effective vaccine

Sputnik V developers offer to share tech with Sanofi-GSK amid vaccine delay

In late November, the Sputnik V developers also offered foreign vaccine producers their help

Sanofi, GSK to provide 200 mn doses of Covid-19 vaccine to global alliance

The facility is part of COVAX, a coalition of governments, health organisations, businesses and charities working to accelerate the development of Covid-19 vaccines

Sanofi and GSK launch trial for protein-based coronavirus vaccine

PARIS (Reuters) - French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments

US to pay Sanofi, GSK $2.1 bn for Covid-19 vaccine to cover 50 mn people

A Sanofi executive said the companies had not yet agreed with the US on a specific price for additional doses

US pledges up to $2.1 billion for Sanofi, GlaxoSmithKline Covid-19 vaccine

Glaxo shares traded 1.6 per cent higher in London, with Sanofi up 1.4 per cent in Paris